Illicit fentanyl has become a national crisis, driving record numbers of drug-related deaths in the United States. According to the Drug Enforcement Administration (DEA), two-thirds of the 107,000+ overdose deaths in 2021 were caused by synthetic opioids like fentanyl and its analogs.
Fearing for their lives, people with substance use disorders and their loved ones are seeking help. But who can they trust? Negligence and unlawful acts by some addiction treatment centers have led to increased public skepticism about their effectiveness. And it can be difficult to identify which treatment facilities have quality recovery programs and which do not.
This executive briefing featured an update on the illcit fentanyl crisis by Uttam Dhillon, former Acting Administrator of the DEA followed by a roundtable discussion led by former U.S. Drug Czar Jim Carroll focused on creating better outcomes in addiction treatment through transparency, compliance, and policy.
Thank you to the panelists and everyone who attended today’s round table discussion at the Tower Club in Ft. Lauderdale.
It was a productive, solution-focused discussion, here are a few key takeaways:
ERPHealth’s enterprise-grade technology leverages the power of patient-reported data to individualize treatment, promote health equity, and position providers as industry leaders. Contact us today to setup a demo and see what ERPHealth can do for your facility.Get Started